Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from EBOS Group Limited ( (AU:EBO) ) is now available.
EBOS Group Limited has announced the allotment of 1,582,542 ordinary shares under a retail offer, which was initially announced on April 10, 2025. This issuance, authorized by a board resolution, represents 0.78484169% of the total class of financial products and is part of the company’s strategic efforts to raise capital, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$39.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a range of products and services including pharmaceuticals, medical supplies, and animal care products. The company is focused on serving markets in New Zealand and Australia.
Average Trading Volume: 61,332
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$7.23B
See more insights into EBO stock on TipRanks’ Stock Analysis page.